EPAS1 and hepatocellular carcinoma: Consequently, the observed absence of beneficial effect of isoform-specific HIFα inhibition on the development of macroscopic HCC lesions, together with upregulated hepatic mRNA expression of HCC tumor markers, discourage the use of HIF-1α and HIF-2α as targets for the treatment of HCC.